0001683168-24-001201.txt : 20240227
0001683168-24-001201.hdr.sgml : 20240227
20240227140223
ACCESSION NUMBER: 0001683168-24-001201
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240119
FILED AS OF DATE: 20240227
DATE AS OF CHANGE: 20240227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cunningham Alex H.
CENTRAL INDEX KEY: 0002013098
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-49709
FILM NUMBER: 24685126
MAIL ADDRESS:
STREET 1: 3753 HOWARD HUGHES PARKWAY
STREET 2: SUITE 200
CITY: LAS VEGAS
STATE: NV
ZIP: 89169
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardiff Lexington Corp
CENTRAL INDEX KEY: 0000811222
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 841044583
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3753 HOWARD HUGHES PARKWAY
STREET 2: SUITE 200
CITY: LAS VEGAS
STATE: NV
ZIP: 89169
BUSINESS PHONE: 844-628-2100
MAIL ADDRESS:
STREET 1: 3753 HOWARD HUGHES PARKWAY
STREET 2: SUITE 200
CITY: LAS VEGAS
STATE: NV
ZIP: 89169
FORMER COMPANY:
FORMER CONFORMED NAME: CARDIFF INTERNATIONAL INC
DATE OF NAME CHANGE: 20000211
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED AMERICAN INC
DATE OF NAME CHANGE: 19910924
FORMER COMPANY:
FORMER CONFORMED NAME: CARDIFF FINANCIAL INC
DATE OF NAME CHANGE: 19890510
4
1
ownership.xml
X0508
4
2024-01-19
0
0000811222
Cardiff Lexington Corp
CDIX
0002013098
Cunningham Alex H.
3753 HOWARD HUGHES PARKWAY, SUITE 200
LAS VEGAS
NV
89169
1
1
1
0
President and CEO
0
Common Stock
1000338
D
Series I Preferred Stock
2024-01-19
4
J
0
62500
0.00
A
2024-01-19
Common Stock
5743000
D
Series A Preferred Stock
Common Stock
1
D
Series B Preferred Stock
Common Stock
6250
D
Series C Preferred Stock
Common Stock
1
D
On January 19, 2024, the Reporting Person received 62,500 shares of Series I Preferred Stock as partial compensation for the Reporting Person's services as Chief Executive Officer of the Issuer. Each share of Series I Preferred Stock is convertible into such number of shares of Common Stock as is determined as follows: (i) if the closing market price of the Common Stock on the principal trading market on which the Common Stock is then traded or quoted is less than $4.00 per share, then each share of Series I Preferred Stock shall be convertible into a number of shares of Common Stock equal to two (2) times the stated value ($4.00 per share), divided by such closing market price on the date of conversion; or (ii) if such closing market price is equal to or greater than $4.00 per share, then each share of Series I Preferred Stock shall be convertible into two (2) shares of Common Stock. The Series I Preferred Stock has no expiration date.
Upon the transfer of any share of Series A Preferred Stock, except for a transfer by the holder to an affiliate, whether such transfer is voluntary or involuntary, such share of Series A Preferred Stock shall automatically, and without any action being required by the Issuer or the Reporting Person, be converted into one (1) share of Common Stock. The Series A Preferred Stock may be converted at any time upon such a transfer and has no expiration date.
Each share of Series B Preferred Stock is convertible at any time into such number of shares of Common Stock as is determined as follows: (i) if the closing market price of the Common Stock on the principal trading market on which the Common Stock is then traded or quoted is less than $4.00 per share, then each share of Series B Preferred Stock shall be convertible into a number of shares of Common Stock equal to two (2) times the stated value ($4.00 per share), divided by such closing market price on the date of conversion; or (ii) if such closing market price is equal to or greater than $4.00 per share, then each share of Series B Preferred Stock shall be convertible into two (2) shares of Common Stock. The Series B Preferred Stock has no expiration date.
Each share of Series C Preferred Stock is convertible at any time into such number of shares of Common Stock as is determined by dividing the stated value ($4.00 per share) by a conversion price of $0.00004. The Series C Preferred Stock has no expiration date.
/s/ Alex Cunningham
2024-02-27